Total Funding
58
Total FundingPost-IPO Equity raised
Growth Score in past quarter
pts
Heat Score 58 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
230798
Vaxil Bio is a biotechnology company that has a novel drug discovery and development platform.
Acquired by 
Green Data Center Real Estate
- Gadi Levin: Chief Executive OfficerPast Role: DarioHealth, CFO
Green Data Center Real Estate
About the Company
Vaxil Bio provides immuno-oncology and infectious disease treatments alone and in combination with other treatments. It is a biotechnology company that has a novel drug discovery and development platform. It offers advantages due to the use of signal peptides as the basis for a prophylactic and therapeutic vaccine.